<DOC>
	<DOCNO>NCT02479386</DOCNO>
	<brief_summary>This study seek good characterize relationship visual function progression ( worsen ) geographic atrophy ( GA ) due age-related macular degeneration ( AMD ) . The study also intend generate new information relationship genetics GA progression . This global , prospective , multicenter , epidemiologic study enrol patient GA secondary AMD . The study visit schedule occur every 6 month . The anticipated duration study 48 month . There plan interim analysis around 2 year time window study .</brief_summary>
	<brief_title>An Epidemiologic Study Disease Progression Patients With Geographic Atrophy Secondary Age-Related Macular Degeneration ( Proxima A ) .</brief_title>
	<detailed_description />
	<mesh_term>Macular Degeneration</mesh_term>
	<mesh_term>Atrophy</mesh_term>
	<mesh_term>Disease Progression</mesh_term>
	<mesh_term>Geographic Atrophy</mesh_term>
	<criteria>Willingness provide Informed Consent &gt; /= 50 year Ability willingness undertake schedule visit assessment For woman postmenopausal ( &gt; /= 12 month nontherapyinduced amenorrhea ) surgically sterile ( absence ovary and/or uterus ) , agreement remain abstinent use single combine contraceptive method result failure rate &lt; 1 % per year least 30 day last fluorescein dye administration The study recruit patient Geographic Atrophy Both Study Eye NonStudy Eye ( Bilateral GA ) evidence prior active choroidal neovascularization ( CNV ) Previous participation study investigational drug GA / dry AMD ( exception study vitamins mineral ) GA either eye due cause AMD History vitrectomy surgery , submacular surgery , surgical intervention AMD Previous laser photocoagulation CNV , diabetic macular edema , retinal vein occlusion , and/or proliferative diabetic retinopathy</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>